Intelligent design: drug targets for the prevention of osteoporosis
Bolander, F.F.
Current Opinion in Investigational Drugs 11(4): 382-384
2010
ISSN/ISBN: 1472-4472 PMID: 20336585 Document Number: 643479
Document emailed within 1 workday
Related Documents
Sheth, S.B.; Colman, R.W. 1995: Regulatory and catalytic domains of platelet cAMP phosphodiesterases: targets for drug design Seminars in Hematology 32(2): 110-119Coleman, R. 2018: Setting the scene, setting the targets. The Joint United Nations Programme on HIV/AIDS prevention targets of 2016 and estimating global pre-exposure prophylaxis targets Sexual Health 15(6): 485-488
Lynn, D.E.; Pearson, J.R.; Pinfield, E.R. 1977: Design of a microprocessor-based intelligent interface Biomedical Sciences Instrumentation 13: 59-62
Martin-Du Pan, R.ém.C. 2009: The evolution according to Darwin, in the era of robotics: hazard, need and intelligent design Revue Medicale Suisse 5(225): 2291-2295
Workman, P. 1997: Towards intelligent anticancer drug screening in the post-genome era? Anti-Cancer Drug Design 12(7): 525-531
Scheen, A.J. 1998: Drug clinics. how i treat various metabolic diseases treated by a drug intervention that targets the intestine Revue Medicale de Liege 53(11): 646-650
Zhao, Y.-m. 2010: Targets and principles for system design of quality control in clinical trials Zhonghua Yi Xue Za Zhi 90(26): 1801-1803
Goin, D.E.; Pearson, R.M.; Craske, M.G.; Stein, A.; Pettifor, A.; Lippman, S.A.; Kahn, K.; Neilands, T.B.; Hamilton, E.L.; Selin, A.; MacPhail, C.; Wagner, R.G.; Gomez-Olive, F.Xavier.; Twine, R.; Hughes, J.P.; Agyei, Y.; Laeyendecker, O.; Tollman, S.; Ahern, J. 2020: Depression and Incident HIV in Adolescent Girls and Young Women in HIV Prevention Trials Network 068: Targets for Prevention and Mediating Factors American Journal of Epidemiology 189(5): 422-432
Williams, M. 2003: Genome-based drug discovery: prioritizing disease-susceptibility/disease-associated genes as novel drug targets for schizophrenia Current Opinion in Investigational Drugs 4(1): 31-36
Jenke, D. 2010: Application of Quality by Design (QbD) Principles to Extractables/Leachables Assessment. Establishing a Design Space for Terminally Sterilized Aqueous Drug Products Stored in a Plastic Packaging System PDA Journal of Pharmaceutical Science and Technology 64(6): 527-535
Ayala, R.C.; Arya, V.; Younis, I.R. 2016: Design Features of Drug-Drug Interaction Trials Between Antivirals and Oral Contraceptives Journal of Clinical Pharmacology 56(5): 541-547
Kutter, E.; Austel, V. 1981: Application of the theory of sets to drug design. Development of a new cardiotonic drug AR-L 115 BS Arzneimittel-Forschung 31(1a): 135-141
Kashyap, A.; Singh, P.Kumar.; Silakari, O. 2018: Counting on Fragment Based Drug Design Approach for Drug Discovery Current Topics in Medicinal Chemistry 18(27): 2284-2293
Guo, Z.-r. 2008: Strategy of molecular drug design: hits, leads and drug candidates Yao Xue Xue Bao 43(9): 898-904
Luna, D.; Otero, C.; Risk, M.; Stanziola, E.; González Bernaldo de Quirós, Fán. 2016: Impact of Participatory Design for Drug-Drug Interaction Alerts. A Comparison Study Between Two Interfaces Studies in Health Technology and Informatics 228: 68-72
Frigeri, A.; Nicchia, G.Paola.; Svelto, M. 2007: Aquaporins as targets for drug discovery Current Pharmaceutical Design 13(23): 2421-2427
Luna, D.R.; Rizzato Lede, D.A.; Rubin, L.; Otero, C.M.; Ortiz, J.M.; García, Mónica.G.; Rapisarda, R.P.; Risk, M.R.; González Bernaldo de Quirós, Fán. 2017: User-Centered Design Improves the Usability of Drug-Drug Interaction Alerts: A Validation Study in the Real Scenario Studies in Health Technology and Informatics 245: 1085-1089
Smith, D.A.; Jones, B. 1999: Variability in drug response as a factor in drug design Current Opinion in Drug Discovery and Development 2(1): 33-41
Dawson, L.; Zwerski, S. 2015: Clinical Trial Design for HIV Prevention Research: Determining Standards of Prevention Bioethics 29(5): 316-323
Hofstadler, S.A.; Griffey, R.H. 2000: Mass spectrometry as a drug discovery platform against RNA targets Current Opinion in Drug Discovery and Development 3(4): 423-431